AstraZeneca PLC (AZN)
77.20
-0.41
(-0.53%)
USD |
NASDAQ |
May 10, 16:00
77.20
0.00 (0.00%)
After-Hours: 19:30
AstraZeneca Free Cash Flow: 5.785B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.785B |
| December 31, 2023 | 6.567B |
| September 30, 2023 | 6.977B |
| June 30, 2023 | 6.561B |
| March 31, 2023 | 6.031B |
| December 31, 2022 | 7.237B |
| September 30, 2022 | 6.093B |
| June 30, 2022 | 5.333B |
| March 31, 2022 | 5.167B |
| December 31, 2021 | 3.763B |
| September 30, 2021 | 4.313B |
| June 30, 2021 | 4.371B |
| March 31, 2021 | 3.895B |
| December 31, 2020 | 2.193B |
| September 30, 2020 | 1.933B |
| June 30, 2020 | 1.578B |
| March 31, 2020 | 1.419B |
| December 31, 2019 | 509.00M |
| September 30, 2019 | 1.334B |
| June 30, 2019 | 772.00M |
| March 31, 2019 | 574.00M |
| December 31, 2018 | 1.247B |
| September 30, 2018 | -122.00M |
| June 30, 2018 | 1.568B |
| March 31, 2018 | 1.781B |
| Date | Value |
|---|---|
| December 31, 2017 | 1.958B |
| September 30, 2017 | 2.831B |
| June 30, 2017 | 1.386B |
| March 31, 2017 | 647.00M |
| December 31, 2016 | 1.831B |
| September 30, 2016 | 548.00M |
| June 30, 2016 | 1.314B |
| March 31, 2016 | 2.57B |
| December 31, 2015 | 536.00M |
| September 30, 2015 | 1.873B |
| June 30, 2015 | 2.197B |
| March 31, 2015 | 2.70B |
| December 31, 2014 | 4.306B |
| September 30, 2014 | 4.625B |
| June 30, 2014 | 3.734B |
| March 31, 2014 | 4.017B |
| December 31, 2013 | 5.342B |
| September 30, 2013 | 5.934B |
| June 30, 2013 | 3.027B |
| March 31, 2013 | 2.775B |
| December 31, 2012 | 2.329B |
| September 30, 2012 | 2.736B |
| June 30, 2012 | 6.678B |
| March 31, 2012 | 6.243B |
| December 31, 2011 | 6.524B |
Free Cash Flow Range, Past 5 Years
509.00M
Minimum
Dec 2019
7.237B
Maximum
Dec 2022
4.092B
Average
4.342B
Median
Free Cash Flow Benchmarks
| GSK PLC | 6.584B |
| Amgen Inc | 7.098B |
| Sanofi SA | -- |
| Viking Therapeutics Inc | -54.87M |
| Fusion Pharmaceuticals Inc | -85.69M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.486B |
| Cash from Investing (Quarterly) | -2.413B |
| Cash from Financing (Quarterly) | 2.028B |
| Free Cash Flow Per Share (Quarterly) | 0.2824 |
| Free Cash Flow to Equity (Quarterly) | -4.934B |
| Free Cash Flow to Firm (Quarterly) | 1.116B |
| Free Cash Flow Yield | 2.40% |